AntiThr Cancer Research Results
AntiThr, antithrombotic: Click to Expand ⟱
| Source: |
| Type: |
An antithrombotic agent is a drug that reduces the formation of blood clots.
|
Scientific Papers found: Click to Expand⟱
*Wound Healing↑, *AntiThr↑, *AntiAg↑, eff↑,
*AntiAg↑, *AntiThr↑, *Dose↝,
*AntiThr↑,
eff↑, AntiThr↑, Bacteria↓, LDH↓, TumCP↓, TumCCA↑, Bcl-2↓, Cyt‑c↑, Casp3↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
PSA, |
NA |
|
|
|
*BioAv↝, *other↝, eff↓, TNF-α↓, IL10↑, CXCR4↓, MMP2↓, MMP9↓, TIMP1↑, NF-kB↓, AP-1↓, STAT↓, JNK↓, ERK↓, MAPK↓, PI3K↓, Akt↓, JAK↓, *AntiDiabetic↓, *neuroP↑, *Imm↑, chemoP↑, *AntiThr↑, *AntiAg↑, *antiOx↑, *SOD↑, *GSH↑, *Wound Healing↑, chemoPv↑, *GSTs↑, *NF-kB↓,
Dose↝, TumCP↓, TumCCA↑, Apoptosis↑, TumCMig↓, TumCI↓, angioG↓, *Inflam↓, *antiOx↑, *Bacteria↓, *AntiThr↑, *hepatoP↑, *AntiDiabetic↑, *neuroP↑, AntiCan↑, ChemoSen↑, *BioAv↝, *BioAv↑, eff↑, CDK1↓, CDK2↓, CDK4↓, cJun↓, cFos↓, Apoptosis↑, PI3K↓, Akt↓, E-cadherin↑, MMP2↓, MMP9↓, TOP1↓, BRCA1↓, ROS↑, BAX↑, Bcl-2↓, XIAP↓, MMP↓, STAT3↓, mTOR↓, NF-kB↓, eff↑, toxicity↓, cardioP↑,
*AntiThr↑, eff↑, ER Stress↑, UPR↑, *AntiAg↑, *COX1↓, Risk↓, TumCG↓, Apoptosis↑, HMG-CoA↓, *Inflam↓, *antiOx↓,
*BloodF↑, *NO↑, *AntiAg↑, *AntiThr↑, *antiOx↑, *angioG↑,
*AntiAg↑, *Inflam↓, *AntiThr↑, *Dose↝,
*cardioP↑, *Dose↝, *Dose↝, *toxicity∅, *toxicity↓, *BP↓, *Inflam↓, *Bacteria↓, *Imm↑, *lipid-P↓, *AST↓, *ALAT↓, *AntiAg↑, *ROS↓, *AntiThr↑,
*toxicity∅, *Dose↑, *Bacteria↓, *Inflam↓, *antiOx↑, *AntiDiabetic↑, *hepatoP↑, *AntiCan↑, *AntiThr↑,
*Dose↝, *Bacteria↓, *hepatoP↑, *antiOx↑, *AntiThr↑, *AntiDiabetic↑, *toxicity↝,
*AntiThr↑, *AntiAg↑, *antiOx↑, *Inflam↓,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
HMG-CoA↓, 1, LDH↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 2, Apoptosis↑, 3, BAX↑, 1, Bcl-2↓, 2, Casp3↑, 1, Cyt‑c↑, 1, JNK↓, 1, MAPK↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 1, cJun↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1, UPR↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
BRCA1↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, CDK2↓, 1, CDK4↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
cFos↓, 1, ERK↓, 1, mTOR↓, 1, PI3K↓, 2, STAT↓, 1, STAT3↓, 1, TOP1↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
AP-1↓, 1, E-cadherin↑, 1, MMP2↓, 2, MMP9↓, 2, TIMP1↑, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CXCR4↓, 1, IL10↑, 1, JAK↓, 1, NF-kB↓, 2, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 1, eff↓, 1, eff↑, 5,
Clinical Biomarkers(tgid=22) ⓘ
BRCA1↓, 1, LDH↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, cardioP↑, 1, chemoP↑, 1, chemoPv↑, 1, Risk↓, 1, toxicity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 57
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1, antiOx↑, 6, GSH↑, 1, GSTs↑, 1, lipid-P↓, 1, ROS↓, 1, SOD↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 12, other↝, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 8,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↑, 1, NO↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX1↓, 1, Imm↑, 2, Inflam↓, 6, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, BioAv↝, 2, Dose↑, 1, Dose↝, 5,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, BloodF↑, 1, BP↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiDiabetic↓, 1, AntiDiabetic↑, 3, cardioP↑, 1, hepatoP↑, 3, neuroP↑, 2, toxicity↓, 1, toxicity↝, 1, toxicity∅, 2, Wound Healing↑, 2,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 4,
Total Targets: 36
Scientific Paper Hit Count for: AntiThr, antithrombotic
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1388 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page